Reneo Pharmaceuticals
Chaline Strickland has 18 years of experience in the pharmaceutical industry. Chaline began their career in 2001 as the VP of Clinical and Regulatory Affairs at Ground Zero Pharmaceuticals. Chaline was later promoted to Vice President and then Sr. Director of Clinical Affairs at the same company. In 2019, they moved to Reneo Pharmaceuticals as the Sr. Director of Regulatory Affairs.
Chaline Strickland earned their PharmD from the University of California, San Francisco between 2000 and 2004.
This person is not in any offices
Reneo Pharmaceuticals
Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases.